{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T16:31:33Z","timestamp":1794846693914,"version":"4.9.1"},"reference-count":62,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"unspecified","delay-in-days":49,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Lupus Sci Med"],"accepted":{"date-parts":[[2026,2,2]]},"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To determine if the levels of five urinary biomarkers (UBs), including cluster of differentiation 163 (CD163), monocyte chemoattractant protein-1 (MCP-1), adiponectin, soluble vascular cell adhesion molecule and platelet factor 4 (PF4), measured 24 months after a lupus nephritis (LN) flare are associated with adverse long-term outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We included patients with an LN flare who had a preflare estimated glomerular filtration rate (eGFR) \u226560\u2009mL\/min and stored urine 24\u00b13 months after the flare. The following outcomes were then examined: (1) time to a subsequent LN flare and (2) time to 30% sustained decline in eGFR. UBs were measured by ELISA 24\u00b13 months after the LN flare. The results were normalised to urine creatinine and expressed as pg per mmol of urine creatinine.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>69 patients with LN were included, the median (IQR) follow-up time after their 24-month urinary sample collection was 129 (97.5\u2013150) months. 50 patients achieved a primary efficacy renal response 24 months after the LN flare. This subcohort of patients had significantly lower UB levels. In this subcohort, 27 (54%) experienced a subsequent LN flare with a median time to flare (IQR) of 3.5 (1.67\u20136.87) years, and 10 (20%) had a 30% decline in eGFR at a median time of 4.38 (3.73\u20135.33) years after their 24-month urinary sample collection. Elevated levels of MCP-1 (HR 1.40 (1.11\u20131.76), p=0.004) and CD163 (HR 1.14 (1.00\u20131.38), p=0.01) predicted a subsequent LN flare. While CD163 (HR 1.16 (1.02\u20131.32), p=0.02), MCP-1 (HR 1.33 (1.01\u20131.74), p=0.04), adiponectin (HR 2.67 (1.68\u20132.46), p&lt;0.001) and PF4 (HR 1.14 (1.04\u20131.25), p=0.002) predicted a 30% decline in eGFR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>UBs measured 24\u00b13 months after an LN flare were associated with subsequent flares and a clinically meaningful decline in kidney function.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/lupus-2025-001724","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T15:40:13Z","timestamp":1771515613000},"page":"e001724","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Measurements of urinary biomarkers at 2 years following a lupus nephritis flare are associated with subsequent renal outcomes"],"prefix":"10.1136","volume":"13","author":[{"given":"Ryan","family":"Baker","sequence":"first","affiliation":[{"name":"Schroeder Arthritis Institute, Krembil Research Institute, University Health Network, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5762-4469","authenticated-orcid":false,"given":"Laura Patricia","family":"Whittall Garcia","sequence":"additional","affiliation":[{"name":"Schroeder Arthritis Institute, Krembil Research Institute, University Health Network, Toronto, Ontario, Canada"},{"name":"University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Schroeder Arthritis Institute, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada"},{"name":"Department of Medicine, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada"},{"name":"Division of Rheumatology, Schroeder Arthritis Institute, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qixuan","family":"Li","sequence":"additional","affiliation":[{"name":"University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Schroeder Arthritis Institute, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada"},{"name":"Department of Biostatistics, University Health Network, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kim","sequence":"additional","affiliation":[{"name":"Schroeder Arthritis Institute, Krembil Research Institute, University Health Network, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennisse","family":"Bonilla","sequence":"additional","affiliation":[{"name":"Schroeder Arthritis Institute, Krembil Research Institute, University Health Network, Toronto, Ontario, Canada"},{"name":"University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Schroeder Arthritis Institute, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9074-0592","authenticated-orcid":false,"given":"Dafna D","family":"Gladman","sequence":"additional","affiliation":[{"name":"Schroeder Arthritis Institute, Krembil Research Institute, University Health Network, Toronto, Ontario, Canada"},{"name":"University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Schroeder Arthritis Institute, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada"},{"name":"Department of Medicine, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada"},{"name":"Division of Rheumatology, Schroeder Arthritis Institute, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7506-9166","authenticated-orcid":false,"given":"Murray","family":"Urowitz","sequence":"additional","affiliation":[{"name":"Schroeder Arthritis Institute, Krembil Research Institute, University Health Network, Toronto, Ontario, Canada"},{"name":"University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Schroeder Arthritis Institute, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada"},{"name":"Department of Medicine, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada"},{"name":"Division of Rheumatology, Schroeder Arthritis Institute, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5177-2076","authenticated-orcid":false,"given":"Zahi","family":"Touma","sequence":"additional","affiliation":[{"name":"Schroeder Arthritis Institute, Krembil Research Institute, University Health Network, Toronto, Ontario, Canada"},{"name":"University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Schroeder Arthritis Institute, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada"},{"name":"Department of Medicine, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada"},{"name":"Division of Rheumatology, Schroeder Arthritis Institute, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5961-9228","authenticated-orcid":false,"given":"Joan","family":"Wither","sequence":"additional","affiliation":[{"name":"Schroeder Arthritis Institute, Krembil Research Institute, University Health Network, Toronto, Ontario, Canada"},{"name":"Department of Medicine, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada"},{"name":"Division of Rheumatology, Schroeder Arthritis Institute, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada"},{"name":"Department of Immunology, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,2,19]]},"reference":[{"key":"2026021907400633000_13.1.e001724.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.reuma.2010.11.001"},{"key":"2026021907400633000_13.1.e001724.2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kev311"},{"key":"2026021907400633000_13.1.e001724.3","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.05040513"},{"key":"2026021907400633000_13.1.e001724.4","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2002.00280.x"},{"key":"2026021907400633000_13.1.e001724.5","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2024-001264","article-title":"Renal response status to predict long-term renal survival in patients with lupus nephritis: results from the Toronto Lupus Cohort","volume":"11","author":"Urowitz","year":"2024","journal-title":"Lupus Sci Med"},{"key":"2026021907400633000_13.1.e001724.6","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2022-000684","article-title":"One-third of patients with lupus nephritis classified as complete responders continue to accrue progressive renal damage despite resolution of proteinuria","volume":"9","author":"Weeding","year":"2022","journal-title":"Lupus Sci Med"},{"key":"2026021907400633000_13.1.e001724.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2018.05.021"},{"key":"2026021907400633000_13.1.e001724.8","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1093\/ckj\/sfac150","article-title":"Kidney biopsy in lupus nephritis after achieving clinical renal remission: paving the way for renal outcome assessment","volume":"15","author":"Lled\u00f3-Ib\u00e1\u00f1ez","year":"2022","journal-title":"Clin Kidney J"},{"key":"2026021907400633000_13.1.e001724.9","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa129"},{"key":"2026021907400633000_13.1.e001724.10","first-page":"840","article-title":"The value of repeat kidney biopsy in quiescent Argentinian lupus nephritis patients","volume":"23","author":"Alvarado","year":"2014","journal-title":"Lupus (Los Angel)"},{"key":"2026021907400633000_13.1.e001724.11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.00443.x"},{"key":"2026021907400633000_13.1.e001724.12","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-016-1120-0","article-title":"A discrete cluster of urinary biomarkers discriminates between active systemic lupus erythematosus patients with and without glomerulonephritis","volume":"18","author":"Landolt-Marticorena","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"2026021907400633000_13.1.e001724.13","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.889931","article-title":"Identification and Validation of a Urinary Biomarker Panel to Accurately Diagnose and Predict Response to Therapy in Lupus Nephritis","volume":"13","author":"Whittall-Garcia","year":"2022","journal-title":"Front Immunol"},{"key":"2026021907400633000_13.1.e001724.14","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2019121285"},{"key":"2026021907400633000_13.1.e001724.15","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/art.40930","article-title":"2019 European League Against Rheumatism\/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus","volume":"71","author":"Aringer","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"2026021907400633000_13.1.e001724.16","doi-asserted-by":"crossref","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"2026021907400633000_13.1.e001724.17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0196117","article-title":"Identification of a neutrophil-related gene expression signature that is enriched in adult systemic lupus erythematosus patients with active nephritis: Clinical\/pathologic associations and etiologic mechanisms","volume":"13","author":"Wither","year":"2018","journal-title":"PLoS One"},{"key":"2026021907400633000_13.1.e001724.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2023.09.002"},{"key":"2026021907400633000_13.1.e001724.19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMOA2102953\/SUPPL_FILE\/NEJMOA2102953_DISCLOSURES.PDF"},{"key":"2026021907400633000_13.1.e001724.20","doi-asserted-by":"publisher","DOI":"10.1002\/art.20364"},{"key":"2026021907400633000_13.1.e001724.21","doi-asserted-by":"publisher","DOI":"10.1002\/art.10142"},{"key":"2026021907400633000_13.1.e001724.22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2001180"},{"key":"2026021907400633000_13.1.e001724.23","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2024-001347","article-title":"Interferon-\u03b1 as a biomarker to predict renal outcomes in lupus nephritis","volume":"11","author":"Whittall Garcia","year":"2024","journal-title":"Lupus Sci Med"},{"key":"2026021907400633000_13.1.e001724.24","doi-asserted-by":"publisher","DOI":"10.1159\/000513566"},{"key":"2026021907400633000_13.1.e001724.25","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.10601016"},{"key":"2026021907400633000_13.1.e001724.26","doi-asserted-by":"publisher","DOI":"10.1093\/biomet\/81.3.515"},{"key":"2026021907400633000_13.1.e001724.27","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.143.1.7063747"},{"key":"2026021907400633000_13.1.e001724.28","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1497.2002.10750.x"},{"key":"2026021907400633000_13.1.e001724.29","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2021-000598","article-title":"Renal response at 2 years post biopsy to predict long-term renal survival in lupus nephritis: a retrospective analysis of the Hopkins Lupus Cohort","volume":"9","author":"Cooper Blenkinsopp","year":"2022","journal-title":"Lupus Sci Med"},{"key":"2026021907400633000_13.1.e001724.30","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.161554"},{"key":"2026021907400633000_13.1.e001724.31","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2012.220"},{"key":"2026021907400633000_13.1.e001724.32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0263778","article-title":"Predicting treatment response and clinicopathological findings in lupus nephritis with urine epidermal growth factor, monocyte chemoattractant protein-1 or their ratios","volume":"17","author":"Ngamjanyaporn","year":"2022","journal-title":"PLoS One"},{"key":"2026021907400633000_13.1.e001724.33","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-017-1498-3","article-title":"Urinary angiostatin, CXCL4 and VCAM-1 as biomarkers of lupus nephritis","volume":"20","author":"Mok","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"2026021907400633000_13.1.e001724.34","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1111\/1756-185X.13197","article-title":"Urine angiostatin and VCAM-1 surpass conventional metrics in predicting elevated renal pathology activity indices in lupus nephritis","volume":"20","author":"Soliman","year":"2017","journal-title":"Int J Rheum Dis"},{"key":"2026021907400633000_13.1.e001724.35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15986-3"},{"key":"2026021907400633000_13.1.e001724.36","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.885307","article-title":"Urine ALCAM, PF4 and VCAM-1 Surpass Conventional Metrics in Identifying Nephritis Disease Activity in Childhood-Onset Systemic Lupus Erythematosus","volume":"13","author":"Soliman","year":"2022","journal-title":"Front Immunol"},{"key":"2026021907400633000_13.1.e001724.37","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfw214"},{"key":"2026021907400633000_13.1.e001724.38","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.172569","article-title":"Urine proteomic signatures of histological class, activity, chronicity, and treatment response in lupus nephritis","volume":"9","author":"Fava","year":"2024","journal-title":"JCI Insight"},{"key":"2026021907400633000_13.1.e001724.39","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtauto.2024.100244","article-title":"Urinary soluble CD163 is useful as \u201cliquid biopsy\u201d marker in lupus nephritis at both diagnosis and follow-up to predict impending flares","volume":"9","author":"Renaudineau","year":"2024","journal-title":"J Transl Autoimmun"},{"key":"2026021907400633000_13.1.e001724.40","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00671","article-title":"Association of Urine sCD163 With Proliferative Lupus Nephritis, Fibrinoid Necrosis, Cellular Crescents and Intrarenal M2 Macrophages","volume":"11","author":"Zhang","year":"2020","journal-title":"Front Immunol"},{"key":"2026021907400633000_13.1.e001724.41","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.161128"},{"key":"2026021907400633000_13.1.e001724.42","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1007\/s00467-023-05888-z","article-title":"Urine biomarker score captures response to induction therapy with lupus nephritis","volume":"38","author":"Cody","year":"2023","journal-title":"Pediatr Nephrol"},{"key":"2026021907400633000_13.1.e001724.43","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1007\/s10067-016-3404-9","article-title":"Longitudinal assessment of monocyte chemoattractant protein-1 in lupus nephritis as a biomarker of disease activity","volume":"35","author":"Gupta","year":"2016","journal-title":"Clin Rheumatol"},{"key":"2026021907400633000_13.1.e001724.44","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1093\/rheumatology\/kez528","article-title":"ALCAM and VCAM-1 as urine biomarkers of activity and long-term renal outcome in systemic lupus erythematosus","volume":"59","author":"Parodis","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"2026021907400633000_13.1.e001724.45","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfv296"},{"key":"2026021907400633000_13.1.e001724.46","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/ndt\/gfad215","article-title":"Tubular toxicity of proteinuria and the progression of chronic kidney disease","volume":"39","author":"Makhammajanov","year":"2024","journal-title":"Nephrol Dial Transplant"},{"key":"2026021907400633000_13.1.e001724.47","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(00)70262-9"},{"key":"2026021907400633000_13.1.e001724.48","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-019-0398-x"},{"key":"2026021907400633000_13.1.e001724.49","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/acr2.11269","article-title":"Renal Mononuclear Phagocytes in Lupus Nephritis","volume":"3","author":"Davidson","year":"2021","journal-title":"ACR Open Rheumatol"},{"key":"2026021907400633000_13.1.e001724.50","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2023-224788"},{"key":"2026021907400633000_13.1.e001724.51","doi-asserted-by":"publisher","DOI":"10.1097\/MNH.0000000000000186"},{"key":"2026021907400633000_13.1.e001724.52","doi-asserted-by":"publisher","DOI":"10.1089\/jir.2008.0027"},{"key":"2026021907400633000_13.1.e001724.53","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.00601.x"},{"key":"2026021907400633000_13.1.e001724.54","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/RHU.0000000000000580","article-title":"Serum Adiponectin Levels in Patients With Systemic Lupus Erythematosus: A Meta-analysis","volume":"23","author":"Dini","year":"2017","journal-title":"J Clin Rheumatol"},{"key":"2026021907400633000_13.1.e001724.55","doi-asserted-by":"publisher","DOI":"10.1016\/j.biochi.2012.06.008"},{"key":"2026021907400633000_13.1.e001724.56","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2012040414"},{"key":"2026021907400633000_13.1.e001724.57","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2011.10.013"},{"key":"2026021907400633000_13.1.e001724.58","doi-asserted-by":"crossref","DOI":"10.1186\/ar2844","article-title":"Adiponectin may contribute to synovitis and joint destruction in rheumatoid arthritis by stimulating vascular endothelial growth factor, matrix metalloproteinase-1, and matrix metalloproteinase-13 expression in fibroblast-like synoviocytes more than proinflammatory mediators","volume":"11","author":"Choi","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"2026021907400633000_13.1.e001724.59","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2013.141","article-title":"The role of adiponectin in the production of IL-6, IL-8, VEGF and MMPs in human endothelial cells and osteoblasts: implications for arthritic joints","volume":"46","author":"Lee","year":"2014","journal-title":"Exp Mol Med"},{"key":"2026021907400633000_13.1.e001724.60","doi-asserted-by":"publisher","DOI":"10.3858\/emm.2012.44.7.049"},{"key":"2026021907400633000_13.1.e001724.61","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1002\/acr.25528","article-title":"2024 American College of Rheumatology (ACR) Guideline for the Screening, Treatment, and Management of Lupus Nephritis","volume":"77","author":"Sammaritano","year":"2025","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2026021907400633000_13.1.e001724.62","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.2025-0390.O048"}],"container-title":["Lupus Science &amp; Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/lupus-2025-001724","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T15:40:17Z","timestamp":1771515617000},"score":1,"resource":{"primary":{"URL":"https:\/\/lupus.bmj.com\/lookup\/doi\/10.1136\/lupus-2025-001724"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,2,19]]},"published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1136\/lupus-2025-001724"],"URL":"https:\/\/doi.org\/10.1136\/lupus-2025-001724","relation":{},"ISSN":["2053-8790"],"issn-type":[{"value":"2053-8790","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]}}}